NCT04676737 - TTHX1114(NM141) in Combination With DWEK/DSO | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 16, 2022

Study Completion Date

January 13, 2023

Conditions

Fuchs' Endothelial DystrophyFuchs DystrophyFuchs

Interventions

DRUG

TTHX1114(NM141)

TTHX1114

Trial Locations (11)

Trefoil Investigational Site 123, Deerfield Beach

Trefoil Investigational Site 119, Fort Myers

Trefoil Investigational Site 120, Cincinnati

Price Vision Group, Indianapolis

Vance Thompson Vision - Sioux Falls, Sioux Falls

Vance Thompson Vision - Fargo, West Fargo

Vance Thompson Vision - Bozeman, Bozeman

Tauber Eye Center, Kansas City

Vance Thompson Vision - Omaha, Omaha

Trefoil Investigational Site 124, Long Beach

North Bay Eye Associates, Petaluma

All Listed Sponsors

lead

Trefoil Therapeutics, Inc.

INDUSTRY